FDA Announces Voluntary Recall of High Blood Pressure Medication

Bassyonni

ago 12 hours

FDA Announces Voluntary Recall of High Blood Pressure Medication

A New Jersey-based pharmaceutical company has initiated a voluntary recall of a high blood pressure medication. This action follows concerns about possible cross-contamination with another medication, as announced by the Food and Drug Administration (FDA).

Details of the Recall

The recall pertains to over 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets marketed under the brand Ziac. The FDA reported that testing of reserve samples detected ezetimibe, a medication typically prescribed for high cholesterol.

Classification of the Recall

The recall has been classified as Class III by the FDA. This classification indicates that exposure to the recalled product is unlikely to lead to adverse health consequences.

About the Manufacturer

The medication is produced by Glenmark Pharmaceuticals Inc., a company situated in Elmwood Park, New Jersey. The specific pills involved in the recall are available in two dosage strengths: 2.5 milligrams and 6.25 milligrams.